Skip to main content
logo
Panacea Biotec Limited (BOM:531349)
India flag India · Delayed Price · Currency is INR
535.35
+1.00 (0.19%)
At close: Jun 19, 2026

Panacea Biotec Revenue

In the fiscal year ending March 31, 2026, Panacea Biotec had annual revenue of 6.40B INR with 14.43% growth. Panacea Biotec had revenue of 1.67B in the quarter ending March 31, 2026, with 25.82% growth.

Revenue
6.40B
Revenue Growth
+14.43%
P/S Ratio
5.14
Revenue / Employee
2.98M
Employees
2,149
Market Cap
32.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20266.40B806.76M14.43%
Mar 31, 20255.59B-740.00K-0.01%
Mar 31, 20245.59B992.22M21.57%
Mar 31, 20234.60B-2.01B-30.44%
Mar 31, 20226.61B364.27M5.83%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aarti Drugs25.65B
Hester Biosciences3.33B
Titan Biotech2.06B
Zenotech Laboratories395.62M
Bharat Immunologicals & Biologicals Corporation76.50M
Hindustan Bio Sciences7.37M
Transgene Biotek2.11M
CCME Global350.00K
Revenue Rankings

Panacea Biotec News

More News